Genzyme board rejects Sanofi bid

August 30, 2010

The board of directors at US biotechnology firm Genzyme has unanimously rejected an 18.5-billion-dollar takeover offer from French pharmaceutical giant Sanofi-Aventis, Genzyme said Monday.

"The Genzyme board of directors met last (Sunday) night (and) unanimously affirmed its previous rejection of Sanofi's proposal," the company said in a statement.

A letter to Sanofi , signed by Genzyme chief executive Henri Termeer, recalled that the board had turned down an earlier offer on August 11.

The latest proposal, it said, "provides no new information and no improvement in price, and therefore fails to establish a basis for engagement by the Genzyme board."

It added that the board was "not prepared to engage in merger negotiations with Sanofi based upon an opportunistic proposal with an unrealistic starting price that dramatically undervalues our company."

Speaking during a telephone conference call, Sanofi chief executive Chris Viehbacher said Genzyme's response was "not surprising."

In an interview appearing Monday in the French financial newspaper Les Echos, Viehbacher said he was in no hurry to pursue a bid to acquire Genzyme.

"We want to show our determination and our seriousness, without appearing to be threatening right away," he told the paper.

"There is still lots of time."

Sanofi-Aventis unveiled its latest 18.5-billion-dollar (14.5-billion-euro) offer for Genzyme on Sunday, hinting it might launch a hostile bid.

Sanofi said it was disclosing to Genzyme's shareholders the contents of its offer, which it initially made in July, after the company's management rejected it on August 11 and declined to enter into talks.

Sanofi said it preferred to enter into constructive talks with Genzyme's management but failing that it was "prepared to consider all alternatives to successfully complete this transaction."

A Sanofi spokesman stressed that for the moment this "is not a hostile offer ... but a proposal addressed to Genzyme's management."

Explore further: EMC raises offer for Data Domain

Related Stories

EMC raises offer for Data Domain

July 6, 2009

Computer storage giant EMC raised its offer to purchase data storage firm Data Domain on Monday in a bid to top a rival offer for the company by data management firm NetApp.

Sanofi to deliver swine flu vaccine in October

September 21, 2009

(AP) -- Sanofi-Aventis SA will begin delivering the first doses of its new swine flu vaccine in the United States by mid-October, the head of France's largest pharmaceutical company said Monday.

Recommended for you

Study suggests fish can experience 'emotional fever'

November 25, 2015

(—A small team of researchers from the U.K. and Spain has found via lab study that at least one type of fish is capable of experiencing 'emotional fever,' which suggests it may qualify as a sentient being. In their ...

New gene map reveals cancer's Achilles heel

November 25, 2015

Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.

Insect DNA extracted, sequenced from black widow spider web

November 25, 2015

Scientists extracted DNA from spider webs to identify the web's spider architect and the prey that crossed it, according to this proof-of-concept study published November 25, 2015 in the open-access journal PLOS ONE by Charles ...

How cells in the developing ear 'practice' hearing

November 25, 2015

Before the fluid of the middle ear drains and sound waves penetrate for the first time, the inner ear cells of newborn rodents practice for their big debut. Researchers at Johns Hopkins report they have figured out the molecular ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.